The inhibition of ATGL-mediated lipolysis by perilipin 5 provides a “lipolytic barrier” against uncontrolled TAG lipolysis in oxidative tissues, thus preventing cardiac, hepatic and muscle lipotoxic injury and insulin resistance [179,180,181,182,183]. The gene discussed is PNPLA2; the disease is Insulin resistance.